ArticleBMJ open2019

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).

Mikkel Jürgens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.